Evolving Role of Stereotactic Body Radiation Therapy in the Management of Spine Metastases: Defining Dose and Dose Constraints

Fabio Y. Moraes, Xuguang Chen, Michael Yan, Daniel E. Spratt, Kristen Redmond, William C. Jackson, Yoshiya (Josh) Yamada

Research output: Contribution to journalReview article

Abstract

When treating solid tumor spine metastases, stereotactic high-dose-per-fraction radiation, given in a single fraction or in a hypofractionated approach, has proved to be a highly effective and safe therapeutic option for any tumor histology, in the setting of de novo therapy, as salvage treatment of local progression after previous radiation, and in the postoperative setting. There are variations in practice based on the clinical presentation, goals of therapy, as well as institutional preferences. As a biologically potent therapy, a thoughtful and careful attention to detail with patient selection, treatment planning, and delivery is crucial for treatment success.

Original languageEnglish (US)
Pages (from-to)167-189
Number of pages23
JournalNeurosurgery clinics of North America
Volume31
Issue number2
DOIs
StatePublished - Apr 2020

Keywords

  • Hypofractionated stereotactic body radiation therapy
  • Reirradiation of spine metastases
  • Spine SBRT
  • Spine radiosurgery dose constraints
  • Stereotactic spine radiosurgery
  • Treatment planning

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Evolving Role of Stereotactic Body Radiation Therapy in the Management of Spine Metastases: Defining Dose and Dose Constraints'. Together they form a unique fingerprint.

  • Cite this